Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. It operates through two segments: Biologics, and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins, cell, gene, and other nucleic acid therapies, induced pluripotent stem cells, oncolytic viruses, vaccines, etc. The Pharma and Consumer Health segment specializes in oral solids, soft gel formulations, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.